In this study, immunohistochemical analysis showed that emodin alone or combined with gemcitabine downregulated the expression of MMP-2 and MMP-9 in orthotopic pancreatic cancer tissues, while gemcitabine had no effect on the expression of MMP-2 and MMP-9. Here, MMP2 is linked to pancreatic neoplasm.